对大型阿尔茨海默病患者队伍的全面描述性分析
Ehsan Yaghmaei1, Attallah Dillard2, Mohammadreza Rezaei1
1Schmid College of Science and Technology, Chapman University, Orange, CA, USA.
Journal of Alzheimer's disease reports
|October 30, 2025
概括
这项研究提供了对美国阿尔茨海默病 (AD) 患者最全面的描述,详细介绍了人口统计,治疗和成本. 这些发现对于推动AD研究和改善患者护理至关重要.
科学领域:
- 老年学是指老年学的学科.
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- 准确估计阿尔茨海默病 (AD) 患病率,患者人口统计,并发症和治疗费用对于推进研究至关重要.
- 了解这些因素对于改善未来AD研究的设计和结果至关重要.
研究的目的:
- 为美国阿尔茨海默病患者提供全面,高准确度的描述性分析.
- 详细介绍患者的人口统计,并发症,治疗计划,保险,成本和生存概率.
主要方法:
- 分析了两个大型,高质量的医疗数据库:Oracle EHR真实世界数据和IQVIA.
- 计算总结统计数据,包括关键变量的比例,平均值和95%置信区间.
主要成果:
- 在诊断后的前五年,对整体生存概率的高精度估计.
- 详细报告药物治疗,人口统计,保险,住院,并发症和年度治疗费用 (总和分类).
结论:
- 这项研究提供了迄今为止对阿尔茨海默病患者的最完整,最详细和最准确的描述性分析.
- 这些发现为参与阿尔茨海默病护理的研究人员,临床医生和政策制定者提供了关键的见解.
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
801
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
801